.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Federal Trade Commission
QuintilesIMS
Dow
Novartis
Baxter
Farmers Insurance
Citi
Mallinckrodt

Generated: June 24, 2017

DrugPatentWatch Database Preview

INDERIDE-40/25 Drug Profile

« Back to Dashboard

What is the patent landscape for Inderide-40/25, and what generic Inderide-40/25 alternatives are available?

Inderide-40/25 is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in INDERIDE-40/25 is hydrochlorothiazide; propranolol hydrochloride. There are thirty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.

Summary for Tradename: INDERIDE-40/25

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list38
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INDERIDE-40/25 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
INDERIDE-40/25
hydrochlorothiazide; propranolol hydrochloride
TABLET;ORAL018031-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Farmers Insurance
Argus Health
Boehringer Ingelheim
Federal Trade Commission
Mallinckrodt
Daiichi Sankyo
Cerilliant
Julphar
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot